There are many questions left unanswered because the outbreak is still in an early stage.
Academic rigour, journalistic flair
Articles on Tuberculosis (TB)
Displaying 81 - 100 of 179 articles
In some communities, over a quarter of the children were misclassified as iron replete whereas they were iron deficient.
Pathogens rapidly evolve resistance to antibiotics. AI could keep us a step ahead of deadly infections.
Obstacles to getting more people with TB treated extend beyond cost. It starts with locating people at greatest risk and expanding preventive treatment programmes.
There are more effective ways to give the tuberculosis vaccine.
Bioinformatics can be applied to a range of problems, such as understanding the genome sequence of organisms or coming up with new drugs.
Hugh Ramsay’s Two girls in white, was painted just two years before he died at the age of 28 in 1906. It is the central work in the National Gallery of Australia’s survey exhibition.
Global health researchers, funders and journals are not walking the talk on equity, diversity and inclusion.
Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
Rapid population ageing has prompted researchers to study disease trends in older South Africans. The aim is to understand the role that specific health conditions play in ageing among rural people.
There’s a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
Treating infectious diseases is a huge challenge because patients often fail to take the medicine for the long duration, especially for tuberculosis. Now there’s a new device that may help.
What should be done to ensure that the SDGs actually change countries’ development trajectories? Here are four practical steps.
The push to end TB requires significant investment into the research and development of new diagnostics and treatments.
Tuberculosis kills more people globally than any other infectious disease. A human-rights approach and investment in quality care are essential to ending the global epidemic.
New research shows that the treatment of drug resistant-TB can be reduced from the current duration of 20 to 24 months to less than a year.
TB outside the lungs accounted for 14% of TB cases recorded globally in 2017.
In Southern Africa, high rates of HIV infection have been the primary driver of TB
Warthogs are an important species in managing bovine TB.
In Manitoba, Canada, researchers have used health databases to better understand how people with tuberculosis interact with the health-care system.
Top contributors
-
Canada Research Chair of Epidemiology & Global Health, McGill University
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Associate Professor, Melbourne Health
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Associate Professor in Paediatrics and Child Health, University of Sydney
-
Extraordinary Senior Lecture in the Department of Global Health, Stellenbosch University
-
Associate Professor of Biomedical Engineering, University of Michigan
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Infectious Diseases Physician and Senior Clinical Lecturer, Liverpool School of Tropical Medicine and Honorary Research Associate, University of Liverpool
-
Associate Professor, Pharmaceutical Sciences, University of the Western Cape
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Head of the Division of Pulmonology, University of Cape Town
